World Hepatitis Day, 28 July 2018.
Worldwide, liver diseases are on the rise, yet patients with liver disease are still experiencing stigma, resulting in a barrier to liver disease awareness and inequity in access to appropriate care.
The Lancet–EASL Commission will identify key challenges and opportunities for tackling the increasing health burden and the changing and diverse landscape of liver diseases in Europe. The Commission will quantify the burden of liver disease in Europe and examine evidence-based health policies that can reduce liver deaths and health inequities, alongside increasing government revenues for health systems dealing with liver diseases. This Commission will address optimal standards of care for patients with liver diseases, particularly closing gaps between primary and secondary care physicians; tackling inequity throughout European countries, both for patients and clinical and research infrastructures; the role of specialty groups beyond hepatology in the multidisciplinary management of liver diseases; improving awareness and education of primary care physicians; and overcoming the stigmatisation of patients with liver diseases.
Read the full article
A nuclear receptor links HIV drugs with liver disease
Physical activity linked to reduced risk of liver cancer
MICROB-PREDICT – €15 million EU funded microbiome research project kicks off